Nov 2 (Reuters) - Admedus Ltd (AHZ)
- Notes recent media speculation about ongoing funding of Admedus Vaccines Pty Ltd and Admedus Immunotherapies (AI) business run by it
- Confirms there has been no change in Co's approach to AI to that previously disclosed to ASX
- Notes Admedus Immunotherapies does not contribute to co's revenue in a material way
- Forums
- ASX - By Stock
- News: AHZ Admedus updates on Admedus Immunotherapies (AI) funding
Nov 2 (Reuters) - Admedus Ltd (AHZ) Notes recent media...
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$12.22 |
Change
0.740(6.45%) |
Mkt cap ! $258.3M |
Open | High | Low | Value | Volume |
$11.50 | $12.25 | $11.49 | $395.2K | 33.29K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100 | $11.70 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.22 | 127 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100 | 11.700 |
1 | 500 | 11.600 |
1 | 1000 | 11.560 |
2 | 270 | 11.000 |
1 | 25 | 10.990 |
Price($) | Vol. | No. |
---|---|---|
12.400 | 500 | 1 |
12.500 | 429 | 1 |
12.850 | 1000 | 1 |
13.000 | 2000 | 1 |
13.200 | 1000 | 1 |
Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |